Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For RY
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -12.10 0.65 0.74
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -5.52 354.37 375.07
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 3.93 86.01 82.76
Cash -12.75 232.05 265.97
Capex 15.32 -0.29 -0.34
Free Cash Flow -14.88 3.14 3.68
Revenue 1.06 23.35 23.10
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin 0.00 1.00 1.00
Operating Margin 57.61 < 0.005 < 0.005
ROA 7.20 < 0.005 < 0.005
ROE 5.64 0.03 0.03
ROIC 65.00 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of RY is permitted for members.
5 Growth
The "Growth Entry" for the Focus of RY is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of RY is permitted for members.